Paying users zone. Data is covered by hidden.

  • Get 1 month access to Bristol-Myers Squibb Co. for $17.99, or

  • get full access to entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

Microsoft Excel LibreOffice Calc

Bristol-Myers Squibb Co. (BMY)


Statement of Cash Flows

Difficulty: Beginner

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company’s statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Bristol-Myers Squibb Co., Consolidated Statement of Cash Flows

USD $ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net earnings hidden hidden hidden hidden hidden
Depreciation and amortization, net hidden hidden hidden hidden hidden
Deferred income taxes hidden hidden hidden hidden hidden
Stock-based compensation hidden hidden hidden hidden hidden
Impairment charges hidden hidden hidden hidden hidden
Pension settlements and amortization hidden hidden hidden hidden hidden
Divestiture gains and royalties hidden hidden hidden hidden hidden
Asset acquisition charges hidden hidden hidden hidden hidden
(Gain) loss on equity investments hidden hidden hidden hidden hidden
Other adjustments hidden hidden hidden hidden hidden
Receivables hidden hidden hidden hidden hidden
Inventories hidden hidden hidden hidden hidden
Accounts payable hidden hidden hidden hidden hidden
Deferred income hidden hidden hidden hidden hidden
Income taxes payable hidden hidden hidden hidden hidden
Other hidden hidden hidden hidden hidden
Changes in operating assets and liabilities hidden hidden hidden hidden hidden
Adjustments to reconcile net earnings to net cash provided by operating activities hidden hidden hidden hidden hidden
Net cash provided by operating activities hidden hidden hidden hidden hidden
Sale and maturities of marketable securities hidden hidden hidden hidden hidden
Purchase of marketable securities hidden hidden hidden hidden hidden
Capital expenditures hidden hidden hidden hidden hidden
Divestiture and other proceeds hidden hidden hidden hidden hidden
Acquisition and other payments hidden hidden hidden hidden hidden
Net cash (used in) provided by investing activities hidden hidden hidden hidden hidden
Short-term debt obligations, net hidden hidden hidden hidden hidden
Issuance of long-term debt hidden hidden hidden hidden hidden
Repayment of long-term debt hidden hidden hidden hidden hidden
Repurchase of common stock hidden hidden hidden hidden hidden
Dividends hidden hidden hidden hidden hidden
Other hidden hidden hidden hidden hidden
Net cash used in financing activities hidden hidden hidden hidden hidden
Effect of exchange rates on cash and cash equivalents hidden hidden hidden hidden hidden
Increase (decrease) in cash and cash equivalents hidden hidden hidden hidden hidden
Cash and cash equivalents at beginning of year hidden hidden hidden hidden hidden
Cash and cash equivalents at end of year hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).

Item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Bristol-Myers Squibb Co.’s net cash provided by operating activities increased from 2016 to 2017 and from 2017 to 2018.
Net cash (used in) provided by investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Bristol-Myers Squibb Co.’s net cash (used in) provided by investing activities declined from 2016 to 2017 and from 2017 to 2018.
Net cash used in financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Bristol-Myers Squibb Co.’s net cash used in financing activities declined from 2016 to 2017 but then slightly increased from 2017 to 2018.